I63.139

Cerebral infarction due to embolism of unspecified carotid artery

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

CMS-HCC V28

HCC249

Ischemic or Unspecified Stroke

CMS-HCC ESRD V24

HCC100

Ischemic or Unspecified Stroke

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

Inherited from I63Cerebral infarction
Includes

occlusion and stenosis of cerebral and precerebral arteries, resulting in cerebral infarction

Excludes 1

neonatal cerebral infarction (P91.82-)

Excludes 2

chronic, without residual deficits (sequelae) (Z86.73) sequelae of cerebral infarction (I69.3-)

Use additional

code, if applicable, to identify status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility (Z92.82) code, if known, to indicate National Institutes of Health Stroke Scale (NIHSS) score (R29.7-)

Inherited from I60-I69Cerebrovascular diseases
Excludes 1

traumatic intracranial hemorrhage (S06.-)

Use additional

code to identify presence of: alcohol abuse and dependence (F10.-) exposure to environmental tobacco smoke (Z77.22) history of tobacco dependence (Z87.891) hypertension (I10-I1A) occupational exposure to environmental tobacco smoke (Z57.31) tobacco dependence (F17.-) tobacco use (Z72.0)

Inherited from chapter 9Diseases of the circulatory system
Excludes 2

certain conditions originating in the perinatal period (P04-P96) certain infectious and parasitic diseases (A00-B99) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) systemic connective tissue disorders (M30-M36) transient cerebral ischemic attacks and related syndromes (G45.-)

Official Guidelines for I63.139

FY 2026 ›